期刊文献+

全膝关节置换围手术期氨甲环酸不同使用方法的有效性和安全性 被引量:64

Perioperative efficiency and safety of different regimen of tranexamic acid on total knee arthroplasty
原文传递
导出
摘要 目的 探讨在全膝关节置换围手术期氨甲环酸不同使用方法的有效性和安全性.方法 2013年2至5月150例行初次单侧全膝关节置换的女性骨关节炎患者随机分为三组,每组50例.分别在关闭切口前静脉滴注氨甲环酸10 mg/kg(单次使用组);关闭切口前静脉滴注氨甲环酸10 mg/kg、术后3h再次按该剂量重复使用(重复使用组);不使用氨甲环酸(对照组).比较三组引流量、总失血量、隐性失血量、术后不同时间血红蛋白、输血患者比例、深静脉血栓和肺栓塞发生率.结果 对照组引流量(447.2±101.9) ml,大于单次使用组(273.6±99.6) ml和重复使用组(168.5±80.8) ml,差异有统计学意义.对照组总失血量(1 100.8±288.3) ml,大于单次使用组(959.1±291.7) ml和重复使用组(818.7±206.9) ml,差异有统计学意义.三组隐性失血量的差异无统计学意义.对照组术后第1、3、5天的血红蛋白均低于单次使用组和重复使用组,重复使用组均高于单次使用组,差异有统计学意义.三组输血患者比例分别为8.0%(4/50)、6.0%(3/50)和22.0%(11/50),对照组高于单次使用组和重复使用组,差异有统计学意义.术后90 d内均未出现症状性深静脉血栓和肺栓塞.结论 全膝关节置换术中关闭切口前静脉滴注氨甲环酸10 mg/kg能有效减少围手术期失血量和降低输血患者比例,术后3h重复使用能进一步减少失血量,但不能进一步降低输血患者比例.使用氨甲环酸不增加深静脉血栓和肺栓塞发生的风险. Objective To explore the perioperative efficiency and safety of different regimen of tranexamic acid (TXA) in total knee arthroplasty (TKA).Methods From February 2013 to May 2013,150 female patients with knee osteoarthritis underwent unilateral TKA were randomly divided into three groups,50 cases in each group.Patients received 10 mg/kg TXA by fast intravenous infusion before closing the wound in first group (single dose group),patients in second group received two doses of 10 mg/kg TXA before closing the wound and 3 hours postoperation (repeated dose group),patients in the third group didn't receive TXA (control group).The postoperative blood loss via drainage,the total blood loss,the hidden blood loss,the postoperative hemoglobin concentration at different times and the numher of patients need blood transfusion were recorded.All patients were observed for detecting deep vein thrombosis (DVT) by the color doppler ultrasonography within 5 days postoperation,and the symptomatic DVT and pulmonary embolism (PE) were observed within 90 days postoperation.Results The blood loss via drainage was significantly less in the single dose group (273.6±99.6 ml) and repeated dose group (168.5±80.8 ml) compared with the control group (447.2±101.9 ml),and it was significantly less in the repeated dose group than the single dose group; the total blood loss was significantly less in the single dose group (959.1±291.7 ml) and repeated dose group (818.7±206.9 ml) compared with the control group (1 100.8±288.3 ml),and it was significantly less in the repeated dose group than in the single dose group; there was no differ ences about the hidden blood loss among the three groups.The hemoglobin concentration was significantly higher in the single dose group and repeated dose group than in the control group in day 1,3 and 5 postoperation; and it was significantly higher in the repeated dose group compared with the single dose group.The ratio of transfusion was significantly less in the single and repeated dose groups than in the control group,but no differences exists between the single dose group and repeated dose group.There was no DVT in all of the three groups within 5 days postoperation,and there was no symptomatic DVT and PE in all of the three groups within 90 days.Conclusion 10 mg/kg of TXA infused intravenous before closing the wound is effective and safe in TKA,another dose 3 hours postoperation is much more effective and will not increase the danger of DVT and PE.
出处 《中华骨科杂志》 CAS CSCD 北大核心 2014年第6期599-604,共6页 Chinese Journal of Orthopaedics
基金 卫生行业科研专项项目(201302007)
关键词 关节成形术 置换 氨甲环酸 失血 手术 有效性研究 Arthroplasty, replacement, knee Tranexamic acid Blood loss, surgical Validation studies
  • 相关文献

参考文献19

  • 1Charoencholvanich K,Siriwattanasakul P.Tranexamic acid reduces blood loss and blood transfusion after TKA[J].Clin Orthop Relat Res,2011,469(10): 2874-2880.
  • 2Aglietti P,Baldini A,Vena LM,et al.Effect of tourniquet use on activation of coagulation in total knee arthroplasty[J].Clin Orthop Relat Res,2000(371): 169-177.
  • 3Khokhar A,Chari A,Murray D,et al.Venous thromboembolism and its prophylaxis in elective knee arthroplasty: an international perspective[J].Knee,2013,20(3): 170-176.
  • 4中国骨科大手术静脉血栓栓塞症预防指南[J].中华骨科杂志,2009,29(6):602-604. 被引量:530
  • 5Hiippala S,Strid L,Wennerstrand M,et al.Tranexamic acid (Cyklokapron) reduces perioperative blood loss associated with total knee arthroplasty[J].Br J Anaesth,1995,74(5): 534-537.
  • 6Tan J,Chen H,Liu QC,et al.A meta-analysis of the effectiveness and safety of using tranexamic acid in primary unilateral total knee arthroplasty[J].J Surg Res,2013,184(2): 880-887.
  • 7Nadler SB,Hidalgo JU,Bloch T.Prediction of blood volume in normal human adults[J].Surgery,1962,51(2): 224-232.
  • 8Gross JB.Estimating allowable blood loss: corrected for dilution[J].Anesthesiology,1983,58(3): 277-280.
  • 9Benoni G,Bjorkman S,Fredin H.Application of pharmacokinetic data from healthy volunteers for the prediction of plasma concentrations of tranexamic acid in surgical patients[J].Clin Drug Invest,1995,10(5): 280-287.
  • 10Fiechtner BK,Nuttall GA,Johnson ME,et al.Plasma tranexamic acid concentrations during cardiopulmonary bypass[J].Anesth Analg,2001,92(5): 1131-1136.

二级参考文献19

  • 1邱贵兴,杨庆铭,余楠生,翁习生,王凯,李晓林.低分子肝素预防髋、膝关节手术后下肢深静脉血栓形成的多中心研究[J].中华骨科杂志,2006,26(12):819-822. 被引量:428
  • 2Ollendorf DA,Vera-Llonch M,Oster G.Cost of venous thromboembolism following major orthopedic surgery in hospitalized patients.Am J Health Syst Pharm,2002,59(18):1750-1754.
  • 3Geerts WH,Pineo OF,Heir JA,et al.Prevention of venous thromboembolism:the Seventh ACCP Conference on Antithromboric and Thrombolytic Therapy.Chest,2004,126 (3 Suppl):S338-400.
  • 4Mosby's Dictionary of Medicine,Nursing & Health Professions.7th ed.St.Louis,MO:Mosby,2006:115-116,335,520,1454,1849,1949.
  • 5Piovella F,Wang CJ,Lu H,et al.Deep-vein thrombosis rates after major Orthopedic surgery in Asia:an epidemiological study based on postoperative screening with centrally adjudicated bilateral venography.J Thromb Haemost,2005,3(12):2664-2670.
  • 6Heir JA,O'Fallon WM,Petterson TM,et al.Relative impact of risk factors for deep vein thrombosis and pulmonary embolism:a population-based study.Arch Intern Med,2002,162 (11):1245-1248.
  • 7Anderson FA Jr,Spencer FA.Risk factors for venous thrombcembolism.Circulation,2003,107(23 Suppl 1):9-16.
  • 8Caprini JA.Thrombosis risk assessment as a guide to quality patient care.Dis Mon,2005,51(2/3):70-78.
  • 9Geerts WH,Heit JA,Clagett GP,et al.Prevention of venous thromboembolism.Chest,2001,119(1 Suppl):S132-175.
  • 10Snow V,Qaseem A,Barry P,et al.Management of venous thromboembolism:a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians.Ann Intern Med,2007,146(3):204-210.

共引文献529

同被引文献485

引证文献64

二级引证文献658

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部